Secondary Prevention of Small Subcortical Strokes Trial (SPS3)
Cerebrovascular Accident, Hypertension

About this trial
This is an interventional treatment trial for Cerebrovascular Accident focused on measuring stroke, hypertension, high blood pressure, lacunar stroke, subcortical stroke, aspirin, clopidogrel
Eligibility Criteria
INCLUSION: Small subcortical ischemic stroke or subcortical TIA. Inclusion criteria are based on TOAST criteria supplemented by required MRI data. All of the following criteria must be met: One of the lacunar stroke clinical syndromes (adapted from Fisher) lasting > 24 hrs within the past 6 months Absence of signs or symptoms of cortical dysfunction such as aphasia, apraxia, agnosia, agraphia, homonymous visual field defect, etc. No ipsilateral cervical carotid stenosis (≥50%) by a reliable imaging modality done in an approved laboratory since the qualifying small subcortical stroke (S3), if hemispheric. No major-risk cardioembolic sources requiring anticoagulation or other specific therapy. Minor-risk cardioembolic sources will be permitted if anticoagulation is not prescribed by the patient's primary care physician. Subcortical TIA with corresponding lesion on DWI. MRI evidence of S3: a. Presence of an S3 (1.5 and 2 cm in diameter corresponding to the qualifying event on DWI; when TIA, ADC image must confirm lesion or T2/FLAIR (hyperintense lesions) (required for all brainstem events) OR multiple S3s on FLAIR/TI(<1.5 cm in diameter) (hypointense lesions) b. Absence of cortical stroke and large subcortical stroke (recent or remote). EXCLUSION: To be eligible for entry into the study, the patient must not meet any of the criteria listed below: Disabling stroke (Modified Rankin Scale less than or equal to 4) Previous intracranial hemorrhage (excluding traumatic) or hemorrhagic stroke Age under 30 years High risk of bleeding (e.g. recurrent GI or GU bleeding, active peptic ulcer disease, etc) Anticipated requirement for long-term use of anticoagulants (e.g. recurrent DVT) or other antiplatelets Prior cortical stroke (diagnosed either clinically or by neuroimaging), or prior cortical or retinal TIA Prior ipsilateral carotid endarterectomy Impaired renal function: GFR <40 Intolerance or contraindications to aspirin or clopidogrel (including thrombocytopenia, prolonged INR) A score < 24 (adjusted for age and education) on the Folstein Mini Mental Status Examination Medical contraindication to MRI Pregnancy or women of child-bearing potential who are not following an effective method of contraception Geographic or social factors making study participation impractical Unable or unwilling to provide informed consent Unlikely to be compliant with therapy/unwilling to return for frequent clinic visits Patients concurrently participating in another study with an investigational drug or device Other likely specific cause of stroke (e.g. dissection, vasculitis, prothrombotic diathesis, drug abuse)
Sites / Locations
- University of Southern Alabama Stroke Center
- Catholic Healthcare West
- Mayo Clinic Scottsdale
- University of Arizona, Department of Neurology
- University of California San Diego Medical Center
- University of California San Francisco-Fresno
- Denver
- Melbourne
- Miami-University of Miami, Miller School of Medicine
- Emory University, Grady Health System
- Mercy Medical Center-Ruan Neurology Clinical Research
- University of Kentucky, Aging/Stroke Program
- Suburban Hospital
- Boston University
- Wayne State
- Henry Ford Hospital, Department of Neurology
- Berman Center
- Mayo Stroke Center KA-SL-13
- University of Washington
- Tenet Health, St. Louis University
- St. John's Mercy
- Cooper University Hospital
- Buffalo
- Helen Hayes Hospital
- Columbia University Medical Center
- Rochester General Hospital
- University of Rochester
- Wake Forest University, Sciences-Neurology
- Case Western
- Metrohealth Medical Center
- Ohio State University, Division of Stroke
- Oregon Health and Science University
- Vanderbilt University Medical Center
- University of Texas Southwestern
- Scurlock Stroke Center
- University of Texas Health Science Center
- University of Washington
- Marshfield Clinic, Department of Neurology
- Medical College of Wisconsin-Neurology
- Calgary Health
- SPS3 Coordinating Center
- Halifax
- Ottawa Hospital General Campus
- Greenfield Park
- McGill-Jewish General
- McGill-Montreal General
- CHA-Hospital de l'Enfant-Jesus
- Hospital Clinico de la Universidad Católica de Chile
- Hospital Naval Almirante Nef, 'Subida Alessandri s/n, Hall A, Oficina 9
- Hospital-Clinica Kennedy
- Hospital de La Universidad Autonoma de Nuevo Leon
- Antiguo Hospital Civil de Guadalajara
- Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zuibrán
- Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez
- Hospital Sabogal Essalud-Unidad de Investigacion
- Hosp. Universitario Germans Trias I Pujol
- Hospital Del Mar, Passeig Marítim 25-29
- Hospital de la Santa Creu I Sant Pau, c/Sant Antoni Maria Claret, 167
- Hospital del Sagrat Cor. Quinta de Salut I'Alianca, c/Viladomat 288
- Hosp. Parc Tauli de Sabadell
- Hosp. de Girona Dr. Josep Trueta
- Hospital La Paz
- Universidad de Santiago de Compostela, Facultad de Medicina y Odontologia
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
Antiplatelet
Blood pressure
Participants receive aspirin + placebo OR aspirin + clopidogrel
The goal of the blood pressure aspect of this trial is to find out if lowering blood pressure after stroke helps to prevent recurrent stroke and preserves cognition.